ArticleCardiovascular and interventional radiology2025
Safety and Feasibility of Endovascular Management of Pediatric Dialysis Access.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the safety and efficacy of pharmacomechanical intervention in the maintenance of pediatric dialysis access fistulas and grafts in the extremities. MATERIALS AND
methodsA retrospective analysis of 67 interventions performed on 17 pediatric patients with dialysis access maintenance interventions was conducted. Use of angioplasty, stenting, thrombectomy devices, and thrombolytic agents such as tissue plasminogen activator (tPA) were recorded across interventions. Total number of interventions per patient and time between reinterventions were measured. Safety of these techniques was assessed according to the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) complication guidelines. Technical success was defined as restoration of patency without a hemodynamically significant stenosis, and clinical success was defined as symptom resolution without reintervention of greater than 6 months.
resultsThe application of pharmacomechanical intervention demonstrated a favorable safety profile and high technical success rates across all categories. The median age at first intervention was 13 years (IQR 10.1-16.9, range 7-18), and median number of interventions was 2 with a range of 1-11. No major complications were observed during or after the procedures. Among the 67 interventions, angioplasty was the most frequently employed technique (n = 67, 100%), followed by thrombolysis and/or anticoagulation (n = 34, 50.7%), thrombectomy (n = 21, 31.3%), and stenting (n = 10, 14.9%). Technical success was 98.5% (66/67), and combined 6-month primary assisted and secondary patency from the index dialysis circuit intervention was 41.8% (28/67). For patients who received more than one treatment, median time to reintervention was 107 days.
conclusionThe high rate of technical success and absence of major or minor complications suggest that endovascular techniques for dialysis access maintenance including angioplasty, stenting, thrombolysis, and advances therapies can be safely and effectively performed in pediatric patients. Rates of primary and secondary patency are slightly lower compared to the adult population. LEVEL OF EVIDENCE: Level 4, Retrospective Cohort Study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.